Top French court confirms enforcer’s jurisdiction in abuse case

France’s top court has rejected Johnson & Johnson’s attempt to overturn a ruling that upheld the national competition authority’s decision to sanction the drugmaker’s subsidiary for delaying the entry of generic versions of a cancer treatment medication.

Unlock unlimited access to all Global Competition Review content